Clinical Trials Browser

Phase 2 × Bone Neoplasms × anlotinib × Clear all

NCT03527888 2019-05-21

Study of Anlotinib in Patients With Primary Malignant Bone Tumors

Phase 2 Unknown

Bone Neoplasms